Accuray

Accuray is a prominent medical device manufacturer founded in 1990, specializing in advanced radiation oncology systems. The company develops innovative hardware and software solutions designed to deliver precise cancer treatment, enabling clinicians to target tumors with high accuracy while minimizing exposure to healthy tissue. By integrating real-time imaging with adaptive treatment planning, Accuray’s platforms allow medical teams to adjust therapy dynamically during treatment courses. This technological approach addresses critical challenges in oncology, ensuring treatment efficacy while improving patient quality of life across various anatomical sites, including brain, thoracic, and abdominal malignancies.

Operating with a workforce of 500-1,000 employees, Accuray maintains a robust global presence to support hospitals and specialized cancer treatment centers. The organization leverages its technical expertise to expand clinical capabilities for healthcare providers worldwide. Learn about Accuray's global headquarters for detailed information regarding their operational footprint and geographic reach. The company’s commitment to innovation is reflected in its diverse product portfolio, which includes sophisticated delivery systems and information systems that facilitate comprehensive cancer care. These systems are essential for providers seeking to enhance clinical outcomes for patients who may otherwise face limited therapeutic options.

Accuray, traded under the ticker NASDAQ: ARAY, continues to demonstrate significant market activity within the medical device sector. With annual revenue reaching $428.6M, the company maintains a competitive position against various oncology-focused entities. Explore financial highlights to review detailed metrics and funding history. The organization’s leadership and operational teams drive its ongoing development of radiotherapy and radiosurgery technologies. Meet Accuray's team to learn more about theView more...